| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $266.89B | $284.31B | $316.62B | $381.31B | $261.50B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $35.67B | $259.11B | $290.56B | $321.39B | $242.83B |
| R&D | $1.17B | $1.10B | $1.29B | $1.07B | $815.00M |
| SG&A | $12.61B | $12.44B | $13.43B | $12.88B | $11.33B |
| Operating Income | – | – | – | – | – |
| Interest Expense | $4.67B | $4.79B | $4.67B | $3.18B | $3.61B |
| Tax Expense | $11.64B | $13.40B | $12.99B | $21.94B | $9.20B |
| Net Income | $18.12B | $16.52B | $19.64B | $42.87B | $20.63B |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | $5.95B | $6.36B | $6.80B | $7.41B | $7.81B |